{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:09:01Z","timestamp":1777615741899,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T00:00:00Z","timestamp":1537315200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Klin Intensivmed Notfmed"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00063-018-0483-1","type":"journal-article","created":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T05:41:47Z","timestamp":1537335707000},"page":"708-716","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Ulmer Notfallalgorithmus: die\u00a0Akuttherapie von medikamenteninduzierten bradykininvermittelten Angio\u00f6demen","The ulm emergency algorithm for the acute treatment of drug-induced, bradykinin-mediated angioedema"],"prefix":"10.1007","volume":"114","author":[{"given":"J.","family":"Hahn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Bock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.-M.","family":"Muth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Pfaue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. K.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Greve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,19]]},"reference":[{"key":"483_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12245-017-0141-z","author":"JA Bernstein","year":"2017","unstructured":"Bernstein JA, Cremonesi P, Hoffmann TK et\u00a0al (2017) Angioedema in the emergency department: a practical guide to differential diagnosis and management. Int J Emerg Med. \n                    https:\/\/doi.org\/10.1186\/s12245-017-0141-z","journal-title":"Int J Emerg Med"},{"issue":"1","key":"483_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s12016-017-8628-1","volume":"54","author":"S Radonjic-Hoesli","year":"2018","unstructured":"Radonjic-Hoesli S, Hofmeier KS, Micaletto S et al (2018) Urticaria and angioedema: an update on classification and pathogenesis. Clin Rev Allergy Immunol 54(1):88\u2013101","journal-title":"Clin Rev Allergy Immunol"},{"key":"483_CR3","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.jaci.2017.08.029","volume":"140","author":"ME Rothenberg","year":"2017","unstructured":"Rothenberg ME, Saito H, Peebles RS Jr. (2017) Advances in mechanisms of allergic disease in 2016. J\u00a0Allergy Clin Immunol 140:1622\u20131631","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"483_CR4","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1111\/all.13397","volume":"73","author":"T Zuberbier","year":"2018","unstructured":"Zuberbier T, Aberer W, Asero R et\u00a0al (2018) The EAACI\/GA(2)LEN\/EDF\/WAO guideline for the definition, classification, diagnosis and management of urticaria. The 2017 revision and update. Allergy 73(7):1393\u20131414","journal-title":"Allergy"},{"key":"483_CR5","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1001\/2013.jamainternmed.34","volume":"172","author":"S Toh","year":"2012","unstructured":"Toh S, Reichman ME, Houstoun M et al (2012) Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system. Arch Intern Med 172:1582\u20131589","journal-title":"Arch Intern Med"},{"key":"483_CR6","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1161\/HYPERTENSIONAHA.108.110270","volume":"51","author":"DR Miller","year":"2008","unstructured":"Miller DR, Oliveria SA, Berlowitz DR et al (2008) Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors. Hypertension 51:1624\u20131630","journal-title":"Hypertension"},{"key":"483_CR7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4168\/aair.2010.2.3.195","volume":"2","author":"M Sanchez-Borges","year":"2010","unstructured":"Sanchez-Borges M, Gonzalez-Aveledo LA (2010) Angiotensin-converting enzyme inhibitors and angioedema. Allergy Asthma Immunol Res 2:195\u2013198","journal-title":"Allergy Asthma Immunol Res"},{"key":"483_CR8","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S1081-1206(10)60594-7","volume":"100","author":"A Banerji","year":"2008","unstructured":"Banerji A, Clark S, Blanda M et al (2008) Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department. Ann Allergy Asthma Immunol 100:327\u2013332","journal-title":"Ann Allergy Asthma Immunol"},{"key":"483_CR9","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s00106-015-0084-8","volume":"63","author":"J Hahn","year":"2015","unstructured":"Hahn J, Bas M, Hoffmann TK et al (2015) Bradykinin-induced angioedema: definition, pathogenesis, clinical presentation, diagnosis and therapy. HNO 63:885\u2013896","journal-title":"HNO"},{"key":"483_CR10","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1111\/jch.13097","volume":"19","author":"T Brown","year":"2017","unstructured":"Brown T, Gonzalez J, Monteleone C (2017) Angiotensin-converting enzyme inhibitor-induced angioedema: a review of the literature. J Clin Hypertens (Greenwich) 19:1377\u20131382","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"issue":"10","key":"483_CR11","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1111\/all.12680","volume":"70","author":"M Bas","year":"2015","unstructured":"Bas M, Greve J, Strassen U et\u00a0al (2015) Angioedema induced by cardiovascular drugs. New players join old friends. Allergy 70(10):1196\u20131200","journal-title":"Allergy"},{"key":"483_CR12","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1161\/01.CIR.0000029801.86489.50","volume":"106","author":"M Packer","year":"2002","unstructured":"Packer M, Califf RM, Konstam MA et\u00a0al (2002) Comparison of omapatrilat and enalapril in patients with chronic heart failure: the omapatrilat versus enalapril randomized trial of utility in reducing events (OVERTURE). Circulation 106:920\u2013926","journal-title":"Circulation"},{"key":"483_CR13","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1177\/0194599817737974","volume":"158","author":"CM Lawlor","year":"2018","unstructured":"Lawlor CM, Ananth A, Barton BM et al (2018) Pharmacotherapy for angiotensin-converting enzyme inhibitor-induced angioedema: a systematic review. Otolaryngol Head Neck Surg 158:232\u2013239","journal-title":"Otolaryngol Head Neck Surg"},{"key":"483_CR14","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1097\/HJH.0b013e32834b4b9b","volume":"29","author":"L Beltrami","year":"2011","unstructured":"Beltrami L, Zanichelli A, Zingale L et al (2011) Long-term follow-up of 111 patients with angiotensin-converting enzyme inhibitor-related angioedema. J\u00a0Hypertens 29:2273\u20132277","journal-title":"J Hypertens"},{"key":"483_CR15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1159\/000455803","volume":"79","author":"M Bas","year":"2017","unstructured":"Bas M, Storck K, Strassen U (2017) Potential biomarkers for the diagnosis of angiotensin-converting enzyme inhibitor-induced angioedema. ORL J Otorhinolaryngol Relat Spec 79:85\u201392","journal-title":"ORL J. Otorhinolaryngol. Relat. Spec."},{"key":"483_CR16","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/S0196-0644(00)43749-2","volume":"36","author":"RY Lin","year":"2000","unstructured":"Lin RY, Curry A, Pesola GR et\u00a0al (2000) Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonists. Ann Emerg Med 36:462\u2013468","journal-title":"Ann Emerg Med"},{"key":"483_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/1060028015607037","volume":"50","author":"CM Culley","year":"2016","unstructured":"Culley CM, DiBridge JN, Wilson GL Jr. (2016) Off-label use of agents for management of serious or life-threatening angiotensin converting enzyme inhibitor-induced angioedema. Ann Pharmacother 50:47\u201359","journal-title":"Ann Pharmacother"},{"key":"483_CR18","doi-asserted-by":"publisher","first-page":"283","DOI":"10.5811\/westjem.2016.2.29224","volume":"17","author":"RM Curtis","year":"2016","unstructured":"Curtis RM, Felder S, Borici-Mazi R et al (2016) ACE-I angioedema: accurate clinical diagnosis may prevent epinephrine-induced harm. West J Emerg Med 17:283\u2013289","journal-title":"West J Emerg Med"},{"key":"483_CR19","volume-title":"Leitlinie \u201ePolytrauma \/ Schwerverletzten-Behandlung\u201c","author":"B Bouillon","year":"2016","unstructured":"Bouillon B, Pieper D (2016) Leitlinie \u201ePolytrauma \/ Schwerverletzten-Behandlung\u201c. Deutsche Gesellschaft f\u00fcr Unfallchirurgie, Berlin (AWMF Registernummer 012\u2013019)"},{"key":"483_CR20","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00063-012-0090-5","volume":"107","author":"N Pirlich","year":"2012","unstructured":"Pirlich N, Piepho T, Gervais H et\u00a0al (2012) Indirect laryngoscopy\/video laryngoscopy. A review of devices used in emergency and intensive care medicine in Germany. Med Klin Intensivmed Notfmed 107:521\u2013530","journal-title":"Med Klin Intensivmed Notfmed"},{"key":"483_CR21","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1056\/NEJMoa1312524","volume":"372","author":"M Bas","year":"2015","unstructured":"Bas M, Greve J, Stelter K et al (2015) A randomized trial of Icatibant in ACE-inhibitor-induced angioedema. N\u00a0Engl J Med 372:418\u2013425","journal-title":"N Engl J Med"},{"key":"483_CR22","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1016\/j.jaip.2017.03.003","volume":"5","author":"R Sinert","year":"2017","unstructured":"Sinert R, Levy P, Bernstein JA et al (2017) Randomized trial of Icatibant for angiotensin-converting enzyme inhibitor-induced upper airway angioedema. J\u00a0Allergy Clin Immunol Pract 5:1402\u20131409.e3","journal-title":"J Allergy Clin Immunol Pract"},{"key":"483_CR23","doi-asserted-by":"publisher","first-page":"E198","DOI":"10.1002\/lary.25113","volume":"125","author":"J Greve","year":"2015","unstructured":"Greve J, Bas M, Hoffmann TK et al (2015) Effect of C1-esterase-inhibitor in angiotensin-converting enzyme inhibitor-induced angioedema. Laryngoscope 125:E198\u2013E202","journal-title":"Laryngoscope"},{"key":"483_CR24","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1177\/0897190016677427","volume":"30","author":"M Leibfried","year":"2017","unstructured":"Leibfried M, Kovary A (2017) C1 esterase inhibitor (Berinert) for ACE inhibitor-induced angioedema: two case reports. J\u00a0Pharm Pract 30:668\u2013671","journal-title":"J Pharm Pract"},{"key":"483_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2015-212891","author":"S Ostenfeld","year":"2015","unstructured":"Ostenfeld S, Bygum A, Rasmussen ER (2015) Life-threatening ACE inhibitor-induced angio-oedema successfully treated with Icatibant: a Bradykinin receptor antagonist. BMJ Case Rep. \n                    https:\/\/doi.org\/10.1136\/bcr-2015-212891","journal-title":"BMJ Case Rep."},{"key":"483_CR26","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1002\/lary.25163","volume":"125","author":"U Strassen","year":"2015","unstructured":"Strassen U, Bas M, Hoffmann TK et al (2015) Treatment of angiotensin receptor blocker-induced angioedema: a case series. Laryngoscope 125:1619\u20131623","journal-title":"Laryngoscope"}],"container-title":["Medizinische Klinik - Intensivmedizin und Notfallmedizin"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-018-0483-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00063-018-0483-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-018-0483-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T16:20:36Z","timestamp":1572970836000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00063-018-0483-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,19]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["483"],"URL":"https:\/\/doi.org\/10.1007\/s00063-018-0483-1","relation":{},"ISSN":["2193-6218","2193-6226"],"issn-type":[{"value":"2193-6218","type":"print"},{"value":"2193-6226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,19]]},"assertion":[{"value":"11 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"J.\u00a0Hahn erhielt unabh\u00e4ngig von der vorgelegten Arbeit nichtfinanzielle Unterst\u00fctzung von den Firmen Shire Deutschland GmbH und CSL Behring. T.K.\u00a0Hoffmann erhielt unabh\u00e4ngig von der vorgelegten Arbeit Vortragshonorare von der Firma Shire Deutschland GmbH. J.\u00a0Greve erhielt unabh\u00e4ngig von der vorgelegten Arbeit Zusch\u00fcsse von der Firma BioCryst Pharmaceuticals, nichtfinanzielle Unterst\u00fctzung von den Firmen Shire Deutschland GmbH, Jerini AG, ViroPharma GmbH und CSL Behring sowie pers\u00f6nliche Honorare von den Firmen Shire Deutschland GmbH und ViroPharma GmbH. J. Greve war unabh\u00e4ngig von der vorliegenden Arbeit als Pr\u00fcfarzt in einer von den Firmen Jerini AG und ViroPharma GmbH gesponserten wissenschaftlichen Studie t\u00e4tig. B.\u00a0Bock, C.-M.\u00a0Muth, A.\u00a0Pfaue und D.\u00a0Friedrich geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Alle beschriebenen Untersuchungen (hier betreffend die retrospektive Analyse) wurden mit Zustimmung der zust\u00e4ndigen Ethik-Kommission durchgef\u00fchrt.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}